Effectiveness and Safety of Switching to Ravulizumab From Eculizumab in Kidney Transplant Recipients With Atypical Hemolytic Uremic Syndrome: A Global aHUS Registry Analysis

Documenti analoghi

• Food Insecurity in Pediatric Kidney Transplant Recipients
  di: Priya S. Verghese, et al.
  Pubblicazione: (2025)
• Eculizumab as Salvage Treatment for Thrombotic Microangiopathy After Lung Transplantation
  di: Hernando Trujillo, et al.
  Pubblicazione: (2024)
• Autoimmune Hemolytic Anemia Following Kidney Transplant: The Role of Tacrolimus and Transition to Everolimus in a Pediatric Case
  di: Mohamed S. Al Riyami, et al.
  Pubblicazione: (2025)
• Single‐Center Outcomes of Conversion to Belatacept in Kidney Transplant Recipients
  di: Eve Carciofi, et al.
  Pubblicazione: (2025)
• Ultrasound Utilization in Hospitalized Kidney Transplant Recipients: Useful or Overused?
  di: Jason T. Bau, et al.
  Pubblicazione: (2024)